Search Results 2301-2310 of 16406 for Chronic Lymphocytic Leukemia
"In the southern United States, Mayo Clinic is the only center that is offering this type of treatment as standard of care for patients with severe autoimmune ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
- New cardio-oncology consultation for acute or chronic leukemia patients; or - New cardio-oncology consultation for multiple myeloma or AL amyloidosis; or
Subject has been recently (within 12 months) diagnosed with acute or chronic pancreatitis OR; A healthy individual, with no known pancreatic disease ...
Clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease ...
Prior diagnosis of multiple myeloma according to IMWG criteriaa , and measurable disease. ... Diagnosis of current smoldering MM, active plasma cell leukemia, ...
NOTE: Pathology reports documenting the diagnosis of NSCLC are required to be reviewed to confirm outside diagnosis. ... Chronic residual toxicity (i.e., ...
Males and females, at least 40 years of age, capable and willing to provide informed consent · Patient must have received a diagnosis of COVID-19 infection ...
Male or female age 40 or older at the time of PD diagnosis. Clinical diagnosis of PD based on bradykinesia plus one of the following: rest tremor or rigidity.
A Study of Determinants of Patient Activation Level of People Living with Chronic Obstructive Pulmonary Disease (COPD) · Overview · Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.